Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28768428 | 0.98 | ALDH1A1 (0.54) | ALDH1A1POLBKMT2ATLR8TSHR | |
| SCHEMBL1155603 | 0.94 | ALDH1A1 (0.50) | ALDH1A1POLBKMT2ATLR8TSHR | |
| Oxalic Acid SCHEMBL27753947 | 0.91 | ALDH1A1 (0.47) | ALDH1A1POLBKMT2ATLR8CYP1A2 | |
| Oxalic Acid SCHEMBL1155033 | 0.90 | ALDH1A1 (0.46) | ALDH1A1POLBKMT2ATLR8CYP1A2 | |
| SCHEMBL950658 | 0.83 | ALDH1A1 (0.53) | ALDH1A1POLBKMT2ATLR8TSHR | |
| SCHEMBL27698630 | 0.82 | ALDH1A1 (0.51) | ALDH1A1POLBKMT2ATLR8TSHR | |
| SCHEMBL6115119 | 0.82 | ALDH1A1 (0.69) | ALDH1A1POLBKMT2ATLR8TSHR | |
| SCHEMBL9935809 | 0.82 | ALDH1A1 (0.63) | ALDH1A1POLBKMT2ATLR8LMNA | |
| SCHEMBL329466 | 0.82 | ALDH1A1 (0.63) | ALDH1A1POLBKMT2ATLR8TSHR | |
| SCHEMBL1049122 | 0.80 | ALDH1A1 (0.61) | ALDH1A1POLBKMT2ATLR8LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7888523-B2 | Preparation of platinum(II) complexes | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2011-02-15 | — | — | US | claimed |
| US-7589225-B2 | Preparation of platinum(II) complexes | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2009-09-15 | — | — | US | claimed |
| US-7576126-B2 | Platinum (II) complexes, preparation and use | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2009-08-18 | — | — | US | claimed |
| EP-1789427-B1 | PREPARATION OF PLATINUM(II) COMPLEXES | PLATCO TECHNOLOGIES PROPRIETAR (ZA) | 2009-05-20 | — | — | EP | claimed |
| US-20080064895-A1 | Preparation of Platinum(II) Complexes | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2008-03-13 | — | — | US | claimed |
| CN-101018797-A | Preparation of platinum (II) complexes | PLATCO TECHNOLOGIES PROPRIETAR (ZA) | 2007-08-15 | — | — | CN | claimed |
| US-20070167643-A1 | Platinum (II) complexes, preparation and use | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2007-07-19 | — | — | US | claimed |
| EP-1789427-A1 | PREPARATION OF PLATINUM(II) COMPLEXES | Platco Technologies (Proprietary) Limited (ZA) | 2007-05-30 | — | — | EP | claimed |
| EP-1704156-A1 | PLATINUM(II) COMPLEXES, PREPARATION AND USE | Platco Technologies (Proprietary) Limited (ZA) | 2006-09-27 | — | — | EP | claimed |
| WO-2006024897-A1 | PREPARATION OF PLATINUM(II) COMPLEXES | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2006-03-09 | — | — | WO | claimed |
| WO-2005051966-A1 | PLATINUM(II) COMPLEXES, PREPARATION AND USE | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2005-06-09 | — | — | WO | claimed |
| EP-2011798-B1 | Preparation of platinum (II) complexes | PLATCO TECHNOLOGIES PROPRIETARY LTD (ZA) | 2011-06-29 | — | — | EP | disclosed |
| EP-2330110-A1 | Platinum(II) complexes, preparation and use | Platco Technologies (Proprietary) Limited (ZA) | 2011-06-08 | — | — | EP | disclosed |
| US-7956208-B2 | Preparation of platinum (II) complexes | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2011-06-07 | — | — | US | disclosed |
| US-7888390-B2 | Preparation of platinum(II) complexes | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2011-02-15 | — | — | US | disclosed |
| US-20070167643-A1 | Platinum (II) complexes, preparation and use | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2007-07-19 | — | — | US | disclosed |
| EP-1789427-A1 | PREPARATION OF PLATINUM(II) COMPLEXES | Platco Technologies (Proprietary) Limited (ZA) | 2007-05-30 | — | — | EP | disclosed |
| EP-1704156-A1 | PLATINUM(II) COMPLEXES, PREPARATION AND USE | Platco Technologies (Proprietary) Limited (ZA) | 2006-09-27 | — | — | EP | disclosed |
| WO-2006024897-A1 | PREPARATION OF PLATINUM(II) COMPLEXES | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2006-03-09 | — | — | WO | disclosed |
| WO-2005051966-A1 | PLATINUM(II) COMPLEXES, PREPARATION AND USE | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2005-06-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070167643-A1 | Platinum (II) complexes, preparation and use | PDCD5, ORC3, PDCD2L | ALDH1A1 3930/4885POLB 155/4885KMT2A 3504/4885 |
| US-20080064895-A1 | Preparation of Platinum(II) Complexes | SLCO4C1, SLC10A6, OTC | ALDH1A1 3885/4885POLB 233/4885KMT2A 2943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.